Skip to main content

Liquidia Corp

LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819576

In the last 90 days, Liquidia Corp insiders filed 0 open-market purchases and 20 sales; 336 institutions reported holding it in 13F filings for Q2 2026, worth $5.78B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Liquidia Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of LQDA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5241−11
Shares10.6M10.3M−318.1K (−3.0%)
Value$30.4M$28.5M−$1.95M (−6.4%)

New holders (0)

Institutions that held Liquidia Corp at the end of Q3 2021 but not at the end of Q2 2021.

None.

Sold out (11)

Institutions that held Liquidia Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of LQDA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Deutsche Bank AG138,853$397.0K
Tibra Equities Europe Ltd118,400$339.0K
JPMorgan Chase & Co79,502$227.0K
Parametric Portfolio Associates LLC38,201$109.0K
ExodusPoint Capital Management, LP21,741$62.0K
XTX Topco Ltd21,756$62.0K
Jump Financial, LLC19,523$56.0K
Walleye Capital LLC13,000$37.0K
Acadian Asset Management LLC11,507$33.0K
Royal Bank of Canada1,647$5.00K
New York State Common Retirement Fund228$1.00K